Temporomandibular Joint Dysfunction

Temporomandibular Joint Dysfunction is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Temporomandibular Joint Disorder · Temporomandibular Joint Disorders · Temporomandibular Joint Syndrome · Temporomandibular Disorders · Temporomandibular Disorder
Classified under: Musculoskeletal and Connective Tissue Diseases
Nervous System Diseases
Physiological and Biological Processes
Signs, Symptoms, and General Pathologies
Stomatognathic Diseases
Indicated drugs: Botulinum toxin type A

Resolves to

Vocabularies

MeSHM0021153ICD-10M26.6SNOMED CT13612005MedDRA10043206UMLSC0039494

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

102Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Temporomandibular Joint Dysfunction share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.